
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
Chi Zhang, Zhao Wu, Jiawen Li, et al.
International Journal of Antimicrobial Agents (2020) Vol. 55, Iss. 5, pp. 105954-105954
Open Access | Times Cited: 1747
Chi Zhang, Zhao Wu, Jiawen Li, et al.
International Journal of Antimicrobial Agents (2020) Vol. 55, Iss. 5, pp. 105954-105954
Open Access | Times Cited: 1747
Showing 1-25 of 1747 citing articles:
The cytokine storm and COVID‐19
Biying Hu, Shaoying Huang, Lianghong Yin
Journal of Medical Virology (2020) Vol. 93, Iss. 1, pp. 250-256
Open Access | Times Cited: 1450
Biying Hu, Shaoying Huang, Lianghong Yin
Journal of Medical Virology (2020) Vol. 93, Iss. 1, pp. 250-256
Open Access | Times Cited: 1450
The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system
Francesca Coperchini, Luca Chiovato, Laura Croce, et al.
Cytokine & Growth Factor Reviews (2020) Vol. 53, pp. 25-32
Open Access | Times Cited: 1280
Francesca Coperchini, Luca Chiovato, Laura Croce, et al.
Cytokine & Growth Factor Reviews (2020) Vol. 53, pp. 25-32
Open Access | Times Cited: 1280
SARS-CoV-2 infection: The role of cytokines in COVID-19 disease
Víctor J. Costela‐Ruiz, Rebeca Illescas‐Montes, José Manuel Puerta-Puerta, et al.
Cytokine & Growth Factor Reviews (2020) Vol. 54, pp. 62-75
Open Access | Times Cited: 1078
Víctor J. Costela‐Ruiz, Rebeca Illescas‐Montes, José Manuel Puerta-Puerta, et al.
Cytokine & Growth Factor Reviews (2020) Vol. 54, pp. 62-75
Open Access | Times Cited: 1078
Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach
Ahmad Abu Turab Naqvi, Kisa Fatima, Taj Mohammad, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2020) Vol. 1866, Iss. 10, pp. 165878-165878
Open Access | Times Cited: 1043
Ahmad Abu Turab Naqvi, Kisa Fatima, Taj Mohammad, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2020) Vol. 1866, Iss. 10, pp. 165878-165878
Open Access | Times Cited: 1043
Why does COVID-19 disproportionately affect older people?
Amber L. Mueller, Maeve S. McNamara, David Sinclair
Aging (2020) Vol. 12, Iss. 10, pp. 9959-9981
Open Access | Times Cited: 968
Amber L. Mueller, Maeve S. McNamara, David Sinclair
Aging (2020) Vol. 12, Iss. 10, pp. 9959-9981
Open Access | Times Cited: 968
Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019
Adeel Zubair, Lindsay McAlpine, Tova Gardin, et al.
JAMA Neurology (2020) Vol. 77, Iss. 8, pp. 1018-1018
Open Access | Times Cited: 879
Adeel Zubair, Lindsay McAlpine, Tova Gardin, et al.
JAMA Neurology (2020) Vol. 77, Iss. 8, pp. 1018-1018
Open Access | Times Cited: 879
Biomarkers associated with COVID-19 disease progression
Giovanni Ponti, Monia Maccaferri, Cristel Ruini, et al.
Critical Reviews in Clinical Laboratory Sciences (2020) Vol. 57, Iss. 6, pp. 389-399
Open Access | Times Cited: 854
Giovanni Ponti, Monia Maccaferri, Cristel Ruini, et al.
Critical Reviews in Clinical Laboratory Sciences (2020) Vol. 57, Iss. 6, pp. 389-399
Open Access | Times Cited: 854
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia
Sara De Biasi, Marianna Meschiari, Lara Gibellini, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 727
Sara De Biasi, Marianna Meschiari, Lara Gibellini, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 727
An Update on Current Therapeutic Drugs Treating COVID-19
Renyi Wu, Lujing Wang, Hsiao‐Chen Dina Kuo, et al.
Current Pharmacology Reports (2020) Vol. 6, Iss. 3, pp. 56-70
Open Access | Times Cited: 600
Renyi Wu, Lujing Wang, Hsiao‐Chen Dina Kuo, et al.
Current Pharmacology Reports (2020) Vol. 6, Iss. 3, pp. 56-70
Open Access | Times Cited: 600
Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2
Michele Catanzaro, Francesca Fagiani, Marco Racchi, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 595
Michele Catanzaro, Francesca Fagiani, Marco Racchi, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 595
The Natural History, Pathobiology, and Clinical Manifestations of SARS-CoV-2 Infections
Jatin Machhi, Jonathan Herskovitz, Ahmed M. Senan, et al.
Journal of Neuroimmune Pharmacology (2020) Vol. 15, Iss. 3, pp. 359-386
Open Access | Times Cited: 587
Jatin Machhi, Jonathan Herskovitz, Ahmed M. Senan, et al.
Journal of Neuroimmune Pharmacology (2020) Vol. 15, Iss. 3, pp. 359-386
Open Access | Times Cited: 587
Clinical management of COVID-19
George M. Varghese, Rebecca John, Abi Manesh, et al.
The Indian Journal of Medical Research (2020) Vol. 151, Iss. 5, pp. 401-401
Open Access | Times Cited: 503
George M. Varghese, Rebecca John, Abi Manesh, et al.
The Indian Journal of Medical Research (2020) Vol. 151, Iss. 5, pp. 401-401
Open Access | Times Cited: 503
Immune Phenotyping Based on the Neutrophil-to-Lymphocyte Ratio and IgG Level Predicts Disease Severity and Outcome for Patients With COVID-19
Bicheng Zhang, Xiaoyang Zhou, Chengliang Zhu, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 479
Bicheng Zhang, Xiaoyang Zhou, Chengliang Zhu, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 479
Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper
Sonu Bhaskar, Akansha Sinha, Maciej Banach, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 471
Sonu Bhaskar, Akansha Sinha, Maciej Banach, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 471
Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial
Yang Cao, Jia Wei, Liang Zou, et al.
Journal of Allergy and Clinical Immunology (2020) Vol. 146, Iss. 1, pp. 137-146.e3
Open Access | Times Cited: 456
Yang Cao, Jia Wei, Liang Zou, et al.
Journal of Allergy and Clinical Immunology (2020) Vol. 146, Iss. 1, pp. 137-146.e3
Open Access | Times Cited: 456
Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past
Vibhuti Kumar Shah, Priyanka Firmal, Aftab Alam, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 449
Vibhuti Kumar Shah, Priyanka Firmal, Aftab Alam, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 449
Air Pollution and COVID-19: The Role of Particulate Matter in the Spread and Increase of COVID-19’s Morbidity and Mortality
Silvia Comunian, Dario Dongo, Chiara Milani, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 12, pp. 4487-4487
Open Access | Times Cited: 444
Silvia Comunian, Dario Dongo, Chiara Milani, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 17, Iss. 12, pp. 4487-4487
Open Access | Times Cited: 444
COVID-19 and multiorgan failure: A narrative review on potential mechanisms
Tahmineh Mokhtari, Fatemeh Hassani, Neda Ghaffari, et al.
Journal of Molecular Histology (2020) Vol. 51, Iss. 6, pp. 613-628
Open Access | Times Cited: 423
Tahmineh Mokhtari, Fatemeh Hassani, Neda Ghaffari, et al.
Journal of Molecular Histology (2020) Vol. 51, Iss. 6, pp. 613-628
Open Access | Times Cited: 423
Cigarette Smoke Exposure and Inflammatory Signaling Increase the Expression of the SARS-CoV-2 Receptor ACE2 in the Respiratory Tract
Joan C. Smith, Erin L. Sausville, Vishruth Girish, et al.
Developmental Cell (2020) Vol. 53, Iss. 5, pp. 514-529.e3
Open Access | Times Cited: 393
Joan C. Smith, Erin L. Sausville, Vishruth Girish, et al.
Developmental Cell (2020) Vol. 53, Iss. 5, pp. 514-529.e3
Open Access | Times Cited: 393
Targeting the NLRP3 Inflammasome in Severe COVID-19
Tracey Freeman, Talia H. Swartz
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 388
Tracey Freeman, Talia H. Swartz
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 388
Multisystem Inflammatory Syndrome in Children Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection (MIS-C): A Multi-institutional Study from New York City
Shubhi Kaushik, Scott I. Aydin, Kim R. Derespina, et al.
The Journal of Pediatrics (2020) Vol. 224, pp. 24-29
Open Access | Times Cited: 377
Shubhi Kaushik, Scott I. Aydin, Kim R. Derespina, et al.
The Journal of Pediatrics (2020) Vol. 224, pp. 24-29
Open Access | Times Cited: 377
Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches
Yuefei Jin, Wangquan Ji, Haiyan Yang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 364
Yuefei Jin, Wangquan Ji, Haiyan Yang, et al.
Signal Transduction and Targeted Therapy (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 364
COVID-19: A Multidisciplinary Review
Nour Chams, Sana Chams, Reina Badran, et al.
Frontiers in Public Health (2020) Vol. 8
Open Access | Times Cited: 358
Nour Chams, Sana Chams, Reina Badran, et al.
Frontiers in Public Health (2020) Vol. 8
Open Access | Times Cited: 358
COVID-19: clinical course and outcomes of 36 hemodialysis patients in Spain
Marián Goicoechea, Luis Alberto Sánchez Cámara, Nicolás Macías, et al.
Kidney International (2020) Vol. 98, Iss. 1, pp. 27-34
Open Access | Times Cited: 337
Marián Goicoechea, Luis Alberto Sánchez Cámara, Nicolás Macías, et al.
Kidney International (2020) Vol. 98, Iss. 1, pp. 27-34
Open Access | Times Cited: 337
Elevated Troponin in Patients With Coronavirus Disease 2019: Possible Mechanisms
Gregorio Tersalvi, Marco Vicenzi, Davide Calabretta, et al.
Journal of Cardiac Failure (2020) Vol. 26, Iss. 6, pp. 470-475
Open Access | Times Cited: 332
Gregorio Tersalvi, Marco Vicenzi, Davide Calabretta, et al.
Journal of Cardiac Failure (2020) Vol. 26, Iss. 6, pp. 470-475
Open Access | Times Cited: 332